Get the Weekly Intelligence Brief — top committee picks every Sunday.

ATR vs CAI

AptarGroup vs Caris Life Sciences, Inc. — AI-powered side-by-side comparison
ATR
AptarGroup
69
Buy
VS
CAI
Caris Life Sciences, Inc.
57
Watch
MetricATRCAI
AI Score 69 57
Price $134.62 $23.12
P/E Ratio 24.06× 62.22×
ROE 14.7% -93.2%
Revenue Growth YoY
Gross Margin 28.3% 69.7%
Debt / Equity 0.54× 0.76×
Dividend Yield 1.4% 0.0%
RSI (14) 48.2 86.2
Beta 0.382 0.678
Expected Upside +1.6%

AI Committee View

Current Innellis committee reasoning for ATR versus CAI.
ATR leads by 12 points.

ATR scores 69/100 (Buy) versus CAI at 57/100 (Watch).

ATR Committee View
75% agreement
4 analysts

The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
CAI Committee View
50% agreement
4 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 63.0% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • MACD histogram positive -- bullish momentum — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • RSI at 86 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
  • Bollinger bandwidth of 63.0% signals elevated volatility — Risk
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ATR Full Analysis CAI Full Analysis